Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail and online pharmacies and optical outlets. It also offers healthcare consultancy and other services. Aster DM Healthcare Limited was founded in 1987 and is headquartered in Dubai, United Arab Emirates.

Revenue projections:

Revenue projections for ASTERDM
Revenue projections for ASTERDM

Revenues for ASTERDM are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 0.00000
forwardPE 53.51736
debtToEquity 55.25900
earningsGrowth -0.98400
revenueGrowth 0.07600
grossMargins 0.58405
operatingMargins 0.13373
trailingEps 6.32000
forwardEps 9.41000

ASTERDM's forward PE ratio being too high suggests the stock's future gains could be limited, with a potential for price correction. It's critical to weigh this alongside other key fundamental parameters for a comprehensive assessment.
Aster DM Healthcare Limited's low earnings and revenue growth suggest that the company may see declining profits. This indicates potential financial challenges ahead, and could lead to a more cautious outlook from investors.
ASTERDM's negative gross and operating margins signal that the company is not profitable, struggling to cover costs associated with production and operations. This could be a red flag for its financial performance moving forward.
ASTERDM's forward EPS exceeding its trailing EPS reflects expectations of increased profitability for the current year. This suggests that the company is projected to achieve higher earnings than in the previous financial year, signaling positive growth and improved financial health.

Price projections:

Price projections for ASTERDM
Price projections for ASTERDM

ASTERDM's price projections have consistently been revised higher, indicating growing confidence in the company's future potential. Analysts appear more optimistic about ASTERDM's ability to generate strong results going forward.

Recommendation changes over time:

Recommendations trend for ASTERDM
Recommendations trend for ASTERDM


Analysts have been favoring ASTERDM with a buy bias recently, signaling a promising investment opportunity. This optimistic outlook may attract more investors, positioning ASTERDM as a desirable option for those seeking to invest their money in a stable, profitable company with strong growth potential.